Alcolase
PrivateLast Round
Seed
May 17, 2026
Total Funding Raised
$1.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alcolase is a biotechnology company developing an enzyme-based supplement to manage alcohol intolerance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alcolase Comparables
Compare Alcolase with similar companies based on industry and business-model similarity.
Alcolase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 17, 2026 |
Key People
Founding team and executive leadership
Alcolase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ada Ventures | Seed |
| Delphinus Venture Capital | Seed |
| Antler | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
$1.5M round led by Ada Ventures, Antler, and Delphinus Venture Capital.
Alcolase Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alcolase's valuation, stock price, and market status.